-transparent.png){kind=logo}
Patients with severe active active rheumatoid arthritis (RA) have higher than normal plasma concentrations of the complement C3 split-product C3d, indicating increased complement activation. Treatment with steroids reduced plasma C3d levels in these patients. Ten patients with classic or definite RA and high disease activity were studied during six days of treatment with steroids. The C3d plasma concentrations declined in a dose-related manner with an increase in daily prednisolone dosage. However the statistical significance of this relationship did not seem to be high enough to validate the use of serial C3d estimations to monitor changes in disease activity in RA patients during short-term steroid treatment.
E Ernst, and
G T Espersen, and
M V Andersen
July 2005,
Annals of the rheumatic diseases,
E Ernst, and
G T Espersen, and
M V Andersen
January 1980,
The Journal of rheumatology,
E Ernst, and
G T Espersen, and
M V Andersen
August 1983,
Lancet (London, England),
E Ernst, and
G T Espersen, and
M V Andersen
January 1985,
International journal of tissue reactions,
E Ernst, and
G T Espersen, and
M V Andersen
June 1986,
Arthritis and rheumatism,
E Ernst, and
G T Espersen, and
M V Andersen
August 2017,
Journal of immunology (Baltimore, Md. : 1950),
E Ernst, and
G T Espersen, and
M V Andersen
February 1986,
The Journal of rheumatology,
E Ernst, and
G T Espersen, and
M V Andersen
January 1993,
The Journal of rheumatology,
E Ernst, and
G T Espersen, and
M V Andersen
June 1975,
Annals of the New York Academy of Sciences,
E Ernst, and
G T Espersen, and
M V Andersen
September 1951,
Prakticky lekar,
